Best treatments for leukocytosis
4 products may treat leukocytosis. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 4 drugs we list for leukocytosis, all are available as lower-cost generics. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for leukocytosis — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Capsule | — | Generic | $6 | View → | |
| 2 | Not yet rated | Prescription | Capsule | — | Generic | $6 | View → | |
| 3 | Not yet rated | Prescription | Tablet | — | Generic | $6 | View → | |
| 4 | Not yet rated | Prescription | Solution | — | Generic | $6 | View → |
Full ranking · 4 treatments
droxia
Boxed warningPrescriptionFDA-sourced
Droxia (Hydroxyurea) is a medication used to treat Brain Neoplasms, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell Carcinoma.
Pharmacy pays
~$5.86 /30
hydrea
Boxed warningPrescriptionFDA-sourced
Hydrea (Hydroxyurea) is a medication used to treat Brain Neoplasms, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell Carcinoma.
Pharmacy pays
~$5.86 /30
siklos
Boxed warningPrescriptionFDA-sourced
Siklos (Hydroxyurea) is a medication used to treat Brain Neoplasms, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell Carcinoma.
Pharmacy pays
~$5.86 /30
xromi
Boxed warningPrescriptionFDA-sourced
Xromi (Hydroxyurea) is a medication used to treat Brain Neoplasms, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell Carcinoma.
Pharmacy pays
~$5.86 /30
Frequently asked
- What treats leukocytosis?
- Our catalog lists 4 products that may treat leukocytosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
- What is the best-rated treatment for leukocytosis?
- Ratings appear as FDA recall-safety data accumulates for the products that may treat leukocytosis.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.